There’s still time to find a solution to the PMPRB problem, stakeholder writes
Recent data from a range of sources confirms what Canada’s innovative medicines industry has been saying for more than three years now: Health Canada’s recent changes to the Patented Medicine Prices Review Board’s (PMPRB) Patented Medicines Regulations will have a negative impact on patientsâ€...












